Log In
BCIQ
Print this Print this
 

midostaurin (CGP 41251, PKC412)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionFMS-like tyrosine kinase 3 (FLT3; CD135) and stem cell factor (SCF) receptor tyrosine kinase (c-Kit; KIT; CD117) inhibitor
Molecular Target FMS-like tyrosine kinase 3 (FLT3) (CD135) ; Stem cell factor (SCF) receptor tyrosine kinase (c-Kit) (KIT) (CD117)
Mechanism of ActionFMS-like tyrosine kinase 3 (FLT3) inhibitor; Stem cell factor (SCF) receptor tyrosine kinase (c-Kit) (KIT) (CD117) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/21/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today